Search
for
Sort by
Research 481–510 of 971
- Do Anti-androgens Have Potential as Therapeutics for COVID-19?
- Multisystem Inflammatory Syndrome in Adults (MIS-A) and SARS-CoV2: An Evolving Relationship
- Rapidly progressive alopecia areata totalis in a COVID‐19 patient, unresponsive to tofacitinib
- Presentation and Management of Cutaneous Manifestations of COVID-19
- Association between Mineralocorticoid Receptor Antagonist and Mortality in SARS-CoV-2 Patients: A Systematic Review and Meta-Analysis
- MAIT Cells in COVID-19: Heroes, Villains, or Both?
- Drug repurposing of cyclin-dependent kinase inhibitors for neutrophilic acute respiratory distress syndrome and psoriasis
- Sex hormones in SARS-CoV-2 susceptibility: key players or confounders?
- Self-Amplifying RNA Approach for Protein Replacement Therapy
- Rash morphology as a predictor of COVID‐19 severity: A systematic review of the cutaneous manifestations of COVID‐19
- Clomipramine suppresses ACE2-mediated SARS-CoV-2 entry
- Antiandrogens as Therapies for COVID-19: A Systematic Review
- Cepharanthine Dry Powder Inhaler for the Treatment of Acute Lung Injury
- Role of ACE2 polymorphism in COVID-19: impact of age
- A Genome-Wide Association Study and Machine-Learning Algorithm Analysis on the Prediction of Facial Phenotypes by Genotypes in Korean Women
- Telogen effluvium after COVID-19 vaccination among public in Saudi Arabia
- SARS-CoV-2-induced Host Metabolic Reprogram (HMR): Nutritional Interventions for Global Management of COVID-19 and Post-Acute Sequelae of COVID-19 (PASC)
- Mesenchymal stem cell‐derived exosomes for organ development and cell‐free therapy
- Hair Loss and Telogen Effluvium Related to COVID-19: The Potential Implication of Adipose-Derived Mesenchymal Stem Cells and Platelet-Rich Plasma as Regenerative Strategies
- Viable SARS-CoV-2 shedding under remdesivir and dexamethasone treatment
- Cardiac and Renal SARS-CoV-2 Viral Entry Protein Regulation by Androgens and Diet: Implications for Polycystic Ovary Syndrome and COVID-19
- Acute Telogen Effluvium in Patients Recently Infected with SARS-CoV-2
- Intermittent chronic telogen effluvium with an unusual dermoscopic finding following COVID ‐19
- Single-cell transcriptomics reveals the natural product Shi-Bi-Man promotes hair regeneration by activating the FGF pathway in dermal papilla cells
- Increased risk of chronic fatigue and hair loss following COVID-19 in individuals with hypohidrotic ectodermal dysplasia
- Reply to the Letter to the Editor “Androgen deprivation therapy may constitute a more effective prophylactic than therapeutic strategy in COVID-19 patients” by N. Bennani and I. M. Bennani-Baiti
- High‐frequency ultrasonography of the scalp: A comparison between androgenetic alopecia and healthy volunteers
- Undesirable effects of COVID-19 vaccination on Saudi population: A descriptive study, Winter 2022.
- Defining the short-term and long-term skin manifestations of COVID-19: insights after more than three years of the pandemic
- Cutaneous Manifestations in Patients With COVID-19 Treated at a University Hospital in Southern Brazil